Notably, C2 was nonsignificantly different from C1 in both survival and tumor stage analysis (Figure 2C); we thus observed subtle difference between up- and downregulated DEGs being identified as potential targets of m6A regulators (Supplementary Figure S3F and Supplementary Table S5). The gene discussed is METTL3; the disease is neoplasm.